Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

The Cure Starts Now has funded $24,934,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 161 grants at over 100 hospitals in 29 countries.
Gustave Roussy - $101,868
$101,868.00
October 2017
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG
Ospedale Pediatrico Bambino Gesu - $98,987
$98,987.00
October 2017
Investigating the role of DIPG-derived exosomes in tumor growth and invasion
Memorial Sloan Kettering Cancer Center - $100,000
$100,000.00
October 2017
Targeting EZH2 as a therapeutic strategy in DIPG
Dana-Farber Cancer Institute - $82,863
$82,863.00
October 2017
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses
The Hospital of Sick Children - $162,828
$162,828.00
October 2017
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study
Stanford University - $200,000
$200,000.00
October 2017
Targeting neuronal activity regulated DIPG infiltration
Children's Cancer Institute (AU) - $185,706
$185,706.00
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1
Children's National Medical Center - $200,000
$200,000.00
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG
Ann & Robert H. Lurie Children's Hospital - $100,000
$100,000.00
October 2017
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG
Anschutz Medical Campus - $50,000
$50,000.00
September 2017
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.
Massachusetts General Hospital - $50,000
$50,000.00
September 2017
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy
CONNECT Consortium - $893,678.37
$893,678.00
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
University of Massachusetts Medical School - $50,000
$50,000.00
May 2017
Advanced RNAi therapeutics for DIPG
Lucile Packard Children's Hospital Stanford - $50,000
$50,000.00
May 2017
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure
Hospital for Sick Children - $50,000
$50,000.00
September 2016
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma